Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro-Reference-Cited by-同舟云学术

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

Published:2003-12 Issue:49 Volume:278 Page:49164-49170
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Migliaccio Giovanni,Tomassini Joanne E.,Carroll Steven S.,Tomei Licia,Altamura Sergio,Bhat Balkrishen,Bartholomew Linda,Bosserman Michele R.,Ceccacci Alessandra,Colwell Lawrence F.,Cortese Riccardo,De Francesco Raffaele,Eldrup Anne B.,Getty Krista L.,Hou Xiaoli S.,LaFemina Robert L.,Ludmerer Steven W.,MacCoss Malcolm,McMasters Daniel R.,Stahlhut Mark W.,Olsen David B.,Hazuda Daria J.,Flores Osvaldo A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference27 articles.

1. Hepatitis C, Biomedical Research Reports;Liang,2000

2. [22] Inhibition of viral polymerases by chain-terminating substrates: A kinetic analysis

3. Trends in the Design of Nucleoside Analogues as Anti-HIV Drugs

4. [24] Development of nonnucleoside HIV reverse transcriptase inhibitors

5. Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: Nevirapine as a Prototype Drug

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Binding of Nucleotide Inhibitors to the NS5 RdRp of the ZIKA Virus in the Replication Initiation State;Current Medicinal Chemistry;2024-02-12

2. Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients;Hepatology;2023-06-20

3. Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2;Antiviral Research;2023-02

4. RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature;Microbiology Spectrum;2022-10-26

5. An overview on small molecules acting as broad-spectrum agents for yellow fever infection;Expert Opinion on Drug Discovery;2022-06-24